Stevens LA, Greene T, Levey AS. Surrogate end points for clinical trials of kidney disease progression. Clin J Am Soc Nephrol 2006; 1: 874-884
Badve SV, Palmer SC, Hawley CM et al. Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Nephrol Dial Transplant 2016; 31: 1425-1436
Srinivas TR, Oppenheimer F. Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival. Clin Transplant 2015; 29: 644-653
Levey AS, Inker LA, Matsushita K et al. GFR Decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2014; 64: 821-835
White CA, Siegal D, Akbari A et al. Use of kidney function end points in kidney transplant trials: a systematic review. Am J Kidney Dis 2010; 56: 1140-1157
Coupel S, Giral-Classe M, Karam G et al. Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Int 2003; 64: 674-680
Hariharan S, Mcbride MA, Cherikh WS et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311-318
Kasiske BL, Israni AK, Snyder JJ et al. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 2011; 57: 466-475
Moranne O, Maillard N, Fafin C et al. Rate of renal graft function decline after one year is a strong predictor of all-cause mortality: GFR decline associates with mortality. Am J Transplant 2013; 13: 695-706
Wu J, Li H, Huang H et al. Slope of changes in renal function in the first year post-transplantation and one-yr estimated glomerular filtration rate together predict long-termrenal allograft survival: GFR changes in the first year post-transplantation predict survival. Clin Transplant 2010; 24: 862-868
Inker LAL, Heerspink, HJ Mondal, H et al. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. Am J Kidney Dis 2014; 64: 848-859
Clayton PA, Lim WH, Wong G et al. Relationship between eGFR decline and hard outcomes after kidney transplants. J Am Soc Nephrol 2016; 27: 3440-3446
Coresh J, Turin TC, Matsushita K et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; 311: 2518-2531
Mariat C, Alamartine E, Barthelemy J-C et al. Assessing renal graft function in clinical trials: can tests predicting glomerular filtration rate substitute for a reference method?. Kidney Int 2004; 65: 289-297
Masson I, Flamant M, Maillard N et al. MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Transplant J 2013; 95: 1211-1217
Delanaye P, Mariat C. The applicability of eGFR equations to different populations. Nat Rev Nephrol 2013; 9: 513-522
Maillard N, Alamartine E, Berthoux F et al. On the demanding necessity of properly evaluating renal graft function in clinical trials: letter to the editor. Transpl Int 2009; 22: 247-248
Ruggenenti P, Gaspari F, Cannata A et al.; for the GFR-ADPKD Study Group. Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study. PLoS One 2012; 7: e32533
Delanaye P, Melsom T, Ebert N et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: why tomeasure glomerular filtration rate with iohexol?. Clin Kidney J 2016; 9: 700-704
Gera M, Slezak JM, Rule AD et al. Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant 2007; 7: 880-887
Warnock DG. Estimated glomerular filtration rate: fit for what purpose?. Nephron 2016; 134: 43-49
Ku E, Xie D, Shlipak M et al.; the CRIC Study Investigators. Change in measured GFR versus eGFR and CKD outcomes. J Am Soc Nephrol 2016; 27: 2196-2204
Methven S, Gasparini A, Carrero JJ et al. Routinely measured iohexol glomerular filtration rate versus creatinine-based estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: a Swedish Chronic Kidney Disease Registry cohort study. Nephrol Dial Transplant 2017; 32: ii170-ii179
Gill JS, Tonelli M, Mix CH et al. The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1636-1642
Carrero JJ, Grams ME, Sang Y et al. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int 2017; 91: 244-251
Halimi J-M, Buchler M, Al-Najjar A et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007; 7: 618-625
Nauta FL, Bakker SJL, van Oeveren W et al. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis 2011; 57: 733-743
Mariat C, Alamartine E, Afiani A et al. Predicting glomerular filtration rate in kidney transplantation: are the K/DOQI guidelines applicable?. Am J Transplant 2005; 5: 2698-2703
Vincenti F, Larsen C, Durrbach A et al.; Belatacept Study Group. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770-781
Noordzij M, Leffondre K, van Stralen KJ et al. When do we need competing risks methods for survival analysis in nephrology?. Nephrol Dial Transplant 2013; 28: 2670-2677
Buron F, Hadj-Aissa A, Dubourg L et al. Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas. Transplantation 2011; 92: 1005-1011
